{
  "docId": "019de511-5ac1-719e-9048-73050be7204d",
  "docSlug": "8527710dc1faf1056127fa0c5f5eb8f9",
  "documentTitle": "GoodRx | Other Presentation Deck | 11 slides",
  "authorId": "goodrx",
  "authorName": "GoodRx",
  "documentKindSlug": "deck",
  "documentKindLabel": "Deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2021-08-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 10,
  "pageCount": 11,
  "prevPage": 9,
  "nextPage": 11,
  "slideType": "key_takeaways",
  "function": "summarize",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de511-5ac1-719e-9048-73050be7204d/10",
  "deckHref": "/decks/019de511-5ac1-719e-9048-73050be7204d",
  "deckJsonHref": "/decks/019de511-5ac1-719e-9048-73050be7204d.json",
  "deckAnchorHref": "/decks/019de511-5ac1-719e-9048-73050be7204d#slide-10",
  "components": [
    {
      "bbox": {
        "h": 0.65,
        "w": 0.85,
        "x": 0.05,
        "y": 0.225
      },
      "kind": "list",
      "text": "Fastest growing offering with the most attractive economics\nInnovative solutions that address HCPs, patients, and pharma manufacturer challenges\nShifts to digital marketing and solutions by pharma manufacturers create attractive macro tailwinds\nCurrent relationships with pharma manufacturers are sticky and expanding\nAttractive growth opportunity across the pharma manufacturer universe",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0c71886f-4fd1-496d-b4ab-207e5f238ef7",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.18,
        "x": 0.045,
        "y": 0.085
      },
      "kind": "title",
      "text": "Conclusion",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e872c6bf-fd66-4b03-bbbe-eb23430b1b49",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "List presentation",
      "slug": "list-presentation",
      "agent": null,
      "layer": "slide",
      "matchId": "b8994541-c7fc-40bc-9458-729db7fcadbf",
      "evidence": "list/bullet: Fastest growing offering with the most attractive economics, Innovative solutions that address HCPs, patients, and pharma manufacturer challenges",
      "confidence": 0.8
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 10,
      "from": 9,
      "beatId": "c45c6f11-2588-473b-9e34-49a64148f791",
      "arcName": "The Consultant's Gambit",
      "arcSlug": "consultants-gambit",
      "beatName": "Impact & Next Steps",
      "beatSlug": "consultants-gambit-impact-next-steps",
      "evidence": "Market sizing on p9 and conclusion on p10 outline the impact and next steps",
      "position": 4,
      "confidence": 0.8,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    }
  ],
  "loops": [
    {
      "to": 10,
      "from": 5,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "7ef34700-5e12-430f-837e-46e16f3027c1",
      "evidence": "The problem statement and conclusion imply a cost of inaction",
      "position": 0,
      "objective": "What are the costs of not improving Awareness, Access, and Adherence?",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    },
    {
      "to": 10,
      "from": 7,
      "name": "Quick Win Big Bet",
      "slug": "47-quick-win-big-bet",
      "bestFor": "Transformation planning, 100-day plans, resource allocation",
      "matchId": "d5e9f0a4-01d1-446f-bad0-2c2d446f9350",
      "evidence": "GoodRx's solutions and market sizing suggest potential quick wins and big bets",
      "position": 1,
      "objective": "What are the potential quick wins and big bets for pharma manufacturers?",
      "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap",
      "confidence": 0.6,
      "description": "Separate initiatives into immediate wins and longer-term strategic bets"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}